Portfolio Holdings Detail for ISIN IE00BF4RFH31
Stock Name / FundiShares MSCI World Small Cap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWSML(USD) LSE
ETF TickerWLDS(GBP) LSE
ETF TickerIUSN(EUR) F
ETF TickerIUSN.DE(EUR) CXE
ETF TickerWLDS.LS(GBP) CXE
ETF TickerWSML.LS(USD) CXE
ETF TickerWSML.L(GBP) LSE
ETF TickerWLDS.L(GBP) LSE

Holdings detail for AXSM

Stock NameAxsome Therapeutics Inc
TickerAXSM(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS05464T1043
LEI549300EXGR0XLRJEIB95

Show aggregate AXSM holdings

News associated with AXSM

Peek Under The Hood: JHMM Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-19 08:11:32
Roger Jeffs Sells 13,464 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) Director Roger Jeffs sold 13,464 shares of the business’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $123.68, for a total value of $1,665,227.52. Following the completion of the sale, the director owned 57,510 shares in […] - 2025-09-04 05:23:00
Deutsche Bank AG Lowers Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Deutsche Bank AG reduced its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 21.2% during the first quarter, Holdings Channel reports. The institutional investor owned 94,980 shares of the company’s stock after selling 25,567 shares during the period. Deutsche Bank AG’s holdings in Axsome Therapeutics were worth $11,078,000 as of its […] - 2025-08-15 05:17:09
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $189.00 at Royal Bank Of Canada
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective increased by analysts at Royal Bank Of Canada from $184.00 to $189.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective suggests a potential upside of 83.03% from the […] - 2025-08-07 05:30:53
KLP Kapitalforvaltning AS Decreases Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
KLP Kapitalforvaltning AS reduced its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.8% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 8,200 shares of the company’s stock after selling 600 shares during the period. KLP Kapitalforvaltning AS’s holdings in Axsome Therapeutics were worth […] - 2025-07-29 05:28:50
Cerity Partners LLC Raises Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Cerity Partners LLC lifted its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 15.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 5,707 shares of the company’s stock after purchasing an additional 766 shares during the period. Cerity Partners LLC’s holdings in Axsome Therapeutics were worth $666,000 as of […] - 2025-07-25 04:50:58
12,745 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) Acquired by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd purchased a new stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund purchased 12,745 shares of the company’s stock, valued at approximately $1,486,000. A number of other hedge funds have also recently made changes to their positions in AXSM. HighTower Advisors LLC […] - 2025-07-24 06:02:49
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by New York State Common Retirement Fund
New York State Common Retirement Fund raised its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 49.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 33,581 shares of the company’s stock after buying an additional 11,090 […] - 2025-07-22 07:13:06
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC lifted its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 0.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,623 shares of the company’s stock after acquiring an additional 136 […] - 2025-07-17 05:39:38
D.A. Davidson & CO. Has $788,000 Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
D.A. Davidson & CO. reduced its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 17.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,755 shares of the company’s stock after selling 1,475 shares during the quarter. D.A. Davidson […] - 2025-07-10 05:31:08
Head-To-Head Review: Axsome Therapeutics (NASDAQ:AXSM) vs. Rosetta Genomics (OTCMKTS:ROSGQ)
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) and Rosetta Genomics (OTCMKTS:ROSGQ – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, valuation, earnings, risk and dividends. Risk and Volatility Axsome Therapeutics has a beta […] - 2025-07-07 02:28:50
Janney Montgomery Scott LLC Has $1.74 Million Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Janney Montgomery Scott LLC raised its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 8.6% in the 1st quarter, HoldingsChannel reports. The fund owned 14,923 shares of the company’s stock after buying an additional 1,178 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Axsome Therapeutics were worth $1,740,000 at the end […] - 2025-06-27 04:26:52
AXSM Makes Notable Cross Below Critical Moving Average
In trading on Monday, shares of Axsome Therapeutics Inc (Symbol: AXSM) crossed below their 200 day moving average of $102.28, changing hands as low as $101.01 per share. Axsome Therapeutics Inc shares are currently trading down about 1.9% on the day. The chart below shows the - 2025-06-16 12:41:26
GAMMA Investing LLC Increases Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
GAMMA Investing LLC increased its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 38,571.9% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 22,043 shares of the company’s stock after buying an additional 21,986 shares during the quarter. GAMMA Investing […] - 2025-06-13 05:14:47
Rhumbline Advisers Grows Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Rhumbline Advisers boosted its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.9% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 54,760 shares of the company’s stock after acquiring an additional 3,515 shares during the quarter. Rhumbline Advisers’ holdings in Axsome Therapeutics […] - 2025-06-12 05:31:01
HC Wainwright Reiterates “Buy” Rating for Axsome Therapeutics (NASDAQ:AXSM)
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They currently have a $180.00 target price on the stock. HC Wainwright’s price target would suggest a potential upside of 66.54% from the stock’s previous close. Several other […] - 2025-06-12 02:18:55
Needham & Company LLC Cuts Axsome Therapeutics (NASDAQ:AXSM) Price Target to $150.00
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective decreased by Needham & Company LLC from $153.00 to $150.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside of 36.48% from the […] - 2025-06-11 02:44:51
2 Soaring Stocks Wth More Upside Potential
Although fundamental investing wisdom tells us to "buy low," it may still be worthwhile to purchase shares of top companies following significant runs. Any point can be considered low -- even after massive gains -- provided there is plenty of upside left. That brings us to Summit - 2025-06-05 04:19:00
Nuveen Asset Management LLC Increases Stock Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Nuveen Asset Management LLC raised its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 118.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 221,202 shares of the company’s stock after acquiring an additional 119,780 shares during the period. Nuveen Asset Management LLC’s holdings in Axsome Therapeutics were worth $18,716,000 as of its […] - 2025-05-25 06:03:20
Captrust Financial Advisors Sells 2,769 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Captrust Financial Advisors decreased its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 48.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 2,953 shares of the company’s stock after selling 2,769 shares during the period. Captrust Financial Advisors’ holdings in Axsome Therapeutics […] - 2025-05-22 04:47:00
Comerica Bank Sells 3,570 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Comerica Bank trimmed its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 32.6% during the 4th quarter, HoldingsChannel reports. The firm owned 7,374 shares of the company’s stock after selling 3,570 shares during the quarter. Comerica Bank’s holdings in Axsome Therapeutics were worth $624,000 at the end of the most recent reporting period. […] - 2025-05-15 04:52:49
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $162.00
Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its target price lifted by Robert W. Baird from $160.00 to $162.00 in a report released on Tuesday, Marketbeat reports. Robert W. Baird currently has an outperform rating on the stock. Other research analysts have also recently issued research reports about the company. HC Wainwright reaffirmed a “buy” […] - 2025-05-09 03:56:43
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by Price T Rowe Associates Inc. MD
Price T Rowe Associates Inc. MD raised its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 12.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 31,228 shares of the company’s stock after acquiring an additional 3,366 shares during the period. Price T Rowe Associates […] - 2025-05-07 05:50:49
Axsome Therapeutics (NASDAQ:AXSM) Trading Up 5.6% After Earnings Beat
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report)’s stock price was up 5.6% during trading on Monday following a better than expected earnings announcement. The stock traded as high as $117.60 and last traded at $118.54. Approximately 231,459 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 683,737 […] - 2025-05-07 02:24:42
Stocks Close Lower on US Trade Policy Uncertainty
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 10:32:49
Stocks Close Lower on US Trade Policy Uncertainty
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 08:45:35
Stocks Close Lower on US Trade Policy Uncertainty
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 06:31:04
Stocks Close Lower on US Trade Policy Uncertainty
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 03:51:04
Stocks Close Lower on US Trade Policy Uncertainty
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 02:59:18
Stocks Close Lower on US Trade Policy Uncertainty
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 01:28:32

iShares MSCI World Small Cap UCITS ETF USD (Acc) AXSM holdings

DateNumber of AXSM Shares HeldBase Market Value of AXSM SharesLocal Market Value of AXSM SharesChange in AXSM Shares HeldChange in AXSM Base ValueCurrent Price per AXSM Share HeldPrevious Price per AXSM Share Held
2025-11-27 (Thursday)27,738USD 4,187,883USD 4,187,8830USD 0 USD 150.98 USD 150.98
2025-11-26 (Wednesday)27,738AXSM holding decreased by -52USD 4,187,883AXSM holding increased by 9379USD 4,187,883-52USD 9,379 USD 150.98 USD 150.36
2025-11-25 (Tuesday)27,790USD 4,178,504AXSM holding decreased by -23344USD 4,178,5040USD -23,344 USD 150.36 USD 151.2
2025-11-24 (Monday)27,790USD 4,201,848AXSM holding increased by 48910USD 4,201,8480USD 48,910 USD 151.2 USD 149.44
2025-11-21 (Friday)27,790USD 4,152,938AXSM holding increased by 170353USD 4,152,9380USD 170,353 USD 149.44 USD 143.31
2025-11-20 (Thursday)27,790AXSM holding increased by 159USD 3,982,585AXSM holding decreased by -72817USD 3,982,585159USD -72,817 USD 143.31 USD 146.77
2025-11-19 (Wednesday)27,631AXSM holding increased by 1590USD 4,055,402AXSM holding increased by 214875USD 4,055,4021,590USD 214,875 USD 146.77 USD 147.48
2025-11-18 (Tuesday)26,041USD 3,840,527AXSM holding increased by 49999USD 3,840,5270USD 49,999 USD 147.48 USD 145.56
2025-11-17 (Monday)26,041USD 3,790,528AXSM holding increased by 152861USD 3,790,5280USD 152,861 USD 145.56 USD 139.69
2025-11-14 (Friday)26,041AXSM holding decreased by -208USD 3,637,667AXSM holding increased by 31054USD 3,637,667-208USD 31,054 USD 139.69 USD 137.4
2025-11-13 (Thursday)26,249USD 3,606,613AXSM holding decreased by -90821USD 3,606,6130USD -90,821 USD 137.4 USD 140.86
2025-11-12 (Wednesday)26,249USD 3,697,434AXSM holding increased by 32811USD 3,697,4340USD 32,811 USD 140.86 USD 139.61
2025-11-11 (Tuesday)26,249USD 3,664,623AXSM holding increased by 47511USD 3,664,6230USD 47,511 USD 139.61 USD 137.8
2025-11-10 (Monday)26,249USD 3,617,112AXSM holding decreased by -9187USD 3,617,1120USD -9,187 USD 137.8 USD 138.15
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AXSM by Blackrock for IE00BF4RFH31

Show aggregate share trades of AXSM

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-26SELL-52152.000147.973 148.375USD -7,716 112.45 Loss of -1,868 on sale
2025-11-26SELL-52152.000147.973 148.375USD -7,716 112.45 Loss of -1,868 on sale
2025-11-20BUY159149.340142.910 143.553USD 22,825 111.75
2025-11-19BUY1,590149.235144.510 144.982USD 230,522 111.57
2025-11-14SELL-208141.970136.000 136.597USD -28,412 111.08 Loss of -5,307 on sale
2025-10-29BUY104133.330134.910 134.752USD 14,014 109.44
2025-10-21BUY208131.390131.800 131.759USD 27,406 108.73
2025-10-17BUY3,432127.940128.225 128.197USD 439,970 108.50
2025-10-07BUY90118.640120.785 120.571USD 10,851 108.44
2025-09-08SELL-180129.290129.430 129.416USD -23,295 107.80 Loss of -3,892 on sale
2025-08-15BUY90109.215110.048 109.965USD 9,897 107.79
2025-08-07BUY270104.320104.415 104.406USD 28,189 107.80
2025-07-29BUY90100.410101.410 101.310USD 9,118 107.99
2025-07-14BUY180112.330113.330 113.230USD 20,381 107.96
2025-06-30BUY180104.390104.580 104.561USD 18,821 107.97
2025-06-25BUY270103.700104.740 104.636USD 28,252 108.07
2025-06-20SELL-45100.690103.915 103.593USD -4,662 108.20 Profit of 207 on sale
2025-06-12SELL-360106.250108.700 108.455USD -39,044 108.42 Loss of -13 on sale
2025-06-02BUY135107.660108.150 108.101USD 14,594 108.35
2025-05-28BUY90102.990104.410 104.268USD 9,384 108.45
2025-05-14BUY45103.670106.845 106.528USD 4,794 108.67
2025-05-13BUY90105.670110.280 109.819USD 9,884 108.70
2025-05-07BUY135110.860112.940 112.732USD 15,219 108.67
2025-04-28BUY45107.240109.710 109.463USD 4,926 108.46
2025-04-16BUY585104.470104.570 104.560USD 61,168 108.79
2025-04-14BUY90103.530104.220 104.151USD 9,374 108.91
2025-04-08SELL-9097.550103.000 102.455USD -9,221 109.40 Profit of 625 on sale
2025-04-04SELL-9098.860106.285 105.543USD -9,499 109.65 Profit of 370 on sale
2025-03-28BUY450118.530122.970 122.526USD 55,137 109.43
2025-03-12SELL-90119.450122.510 122.204USD -10,998 106.97 Loss of -1,371 on sale
2025-03-04SELL-90125.570127.224 127.059USD -11,435 105.78 Loss of -1,915 on sale
2025-02-28SELL-2,915127.540128.770 128.647USD -375,006 105.08 Loss of -68,697 on sale
2025-02-26SELL-208128.330130.949 130.687USD -27,183 104.34 Loss of -5,481 on sale
2025-02-13BUY52131.680132.135 132.089USD 6,869 99.74
2025-02-12BUY208131.550133.100 132.945USD 27,653 99.10
2025-01-27BUY52102.690105.638 105.343USD 5,478 95.28
2025-01-23BUY52103.890104.100 104.079USD 5,412 94.82
2024-12-09BUY1,87299.760102.300 102.046USD 191,030 94.07
2024-12-04BUY10499.540102.420 102.132USD 10,622 93.53
2024-12-03BUY156100.490102.000 101.849USD 15,888 93.28
2024-11-19BUY31295.46095.545 95.536USD 29,807 90.77
2024-11-18BUY10492.45095.000 94.745USD 9,853 90.67
2024-11-12BUY20899.490101.505 101.303USD 21,071 90.12
2024-11-11BUY5290.98091.610 91.547USD 4,760 90.06
2024-11-07BUY26090.70092.549 92.364USD 24,015 90.01
2024-10-23BUY10492.32093.590 93.463USD 9,720 91.95
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AXSM

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1968,445300138,49249.4%
2025-09-1868,7240169,52940.5%
2025-09-1776,19740235,41232.4%
2025-09-16165,94084332,17250.0%
2025-09-1592,09146186,50049.4%
2025-09-12170,5181,480325,95252.3%
2025-09-1188,85416216,01841.1%
2025-09-1061,1600187,15532.7%
2025-09-09142,408200299,18547.6%
2025-09-08144,3200285,04950.6%
2025-09-05104,4490205,29450.9%
2025-09-0473,2161,801138,76352.8%
2025-09-03141,4770223,16563.4%
2025-09-02170,723300297,32857.4%
2025-08-2964,4241,970131,92648.8%
2025-08-2855,224200123,39944.8%
2025-08-27111,32112228,55948.7%
2025-08-26116,2050242,94147.8%
2025-08-2554,093584115,26746.9%
2025-08-22125,9940268,00847.0%
2025-08-2193,981600186,20250.5%
2025-08-20105,5440162,40265.0%
2025-08-19146,3280321,78045.5%
2025-08-18110,4110419,41026.3%
2025-08-1558,4910149,19939.2%
2025-08-1463,1170124,65350.6%
2025-08-1390,0900217,54041.4%
2025-08-1250,283920155,22232.4%
2025-08-1147,0680126,85737.1%
2025-08-0846,4790126,17936.8%
2025-08-0765,3990143,98345.4%
2025-08-06121,3540208,43958.2%
2025-08-05216,25215377,69057.3%
2025-08-04274,153551441,19662.1%
2025-08-01224,3151,925341,20365.7%
2025-07-31160,8240273,05458.9%
2025-07-30142,2479235,17960.5%
2025-07-29117,5500233,07250.4%
2025-07-28203,714708330,36561.7%
2025-07-25240,45735377,49863.7%
2025-07-24112,0065181,15561.8%
2025-07-23246,8300323,57176.3%
2025-07-22354,9990495,58971.6%
2025-07-21126,6590205,64161.6%
2025-07-18130,79415199,45865.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.